Librizzi, D.; Cabanel, N.; Zavorotnyy, M.; Riehl, E.; Kircher, T.; Luster, M.; Hooshyar Yousefi, B.
Clinical Relevance of [18F]Florbetaben and [18F]FDG PET/CT Imaging on the Management of Patients with Dementia. Molecules 2021, 26, 1282.
https://doi.org/10.3390/molecules26051282
AMA Style
Librizzi D, Cabanel N, Zavorotnyy M, Riehl E, Kircher T, Luster M, Hooshyar Yousefi B.
Clinical Relevance of [18F]Florbetaben and [18F]FDG PET/CT Imaging on the Management of Patients with Dementia. Molecules. 2021; 26(5):1282.
https://doi.org/10.3390/molecules26051282
Chicago/Turabian Style
Librizzi, Damiano, Nicole Cabanel, Maxim Zavorotnyy, Elisabeth Riehl, Tilo Kircher, Markus Luster, and Behrooz Hooshyar Yousefi.
2021. "Clinical Relevance of [18F]Florbetaben and [18F]FDG PET/CT Imaging on the Management of Patients with Dementia" Molecules 26, no. 5: 1282.
https://doi.org/10.3390/molecules26051282
APA Style
Librizzi, D., Cabanel, N., Zavorotnyy, M., Riehl, E., Kircher, T., Luster, M., & Hooshyar Yousefi, B.
(2021). Clinical Relevance of [18F]Florbetaben and [18F]FDG PET/CT Imaging on the Management of Patients with Dementia. Molecules, 26(5), 1282.
https://doi.org/10.3390/molecules26051282